STMicroelectronics vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

STMicroelectronics

LeaderSemiconductors & Hardware

Microcontrollers & Power ICs

Franco-Italian semiconductor giant; ~$13B revenue. STM32 MCU family powers 4B+ IoT/embedded devices. Strong SiC power device position for automotive and industrial markets.

About

STMicroelectronics was formed in 1987 through the merger of Italy's SGS Microelettronica and France's Thomson Semiconducteurs in Geneva, Switzerland. The company has built a comprehensive portfolio spanning microcontrollers (MCUs), MEMS sensors, power management ICs, silicon carbide devices, and wireless connectivity chips serving automotive, industrial, IoT, and consumer electronics markets worldwide.\n\nSTMicro is perhaps best known for its STM32 family of ARM Cortex-M microcontrollers, which power billions of embedded applications from smart home devices and wearables to industrial controllers and medical devices. The company is also a major manufacturer of MEMS inertial sensors (accelerometers, gyroscopes) found in smartphones and automotive safety systems, and has a rapidly growing SiC power device business targeting EV inverters and industrial power converters. STMicro reported revenues of approximately $13 billion in FY2024 and guided for continued mid-to-high single digit growth in 2025 across most end markets.\n\nSTMicro operates 11 main manufacturing sites across Europe and Asia, giving it significant vertical integration and a degree of supply chain resilience. The company is jointly owned by French and Italian state entities holding approximately 27.5%, reflecting its strategic national significance. ST is expanding its Catania (Sicily) SiC manufacturing campus to meet surging EV demand and is a founding partner in multiple European semiconductor ecosystem initiatives.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.